SEATTLE, WA / ACCESS Newswire / May 6, 2026 / Aptevo Therapeutics Inc. (Nasdaq:APVO) today reported new clinical results from its RAINIER frontline acute myeloid leukemia (AML) trial. The Company is ...
Kura Oncology’s fair value estimate has been adjusted slightly higher, from US$31.08 to US$31.17 per share, reflecting a modest refresh to the analyst model. This fine tuning comes as analysts weigh ...
Program Enters Final Stage of Dose OptimizationData Continue to Demonstrate Strong Clinical Activity and Favorable Safety Across an Expanding Frontline Dataset SEATTLE, WA / ACCESS Newswire / May 6, 2 ...
Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced the launch of a U.S. Expanded Access Program (EAP) for up to 250 adults with post-bariatric hypoglycemia (PBH) ...
Morning Overview on MSN
AAA test reveals EVs improved in extreme heat but still hemorrhage 39% of range in winter cold
Your electric vehicle handles a Phoenix summer better than ever. A Minneapolis winter? That’s a different story. AAA’s latest ...
Jamia Millia Islamia VC says all Indians share Mahadev DNA at RSS linked event, BJP backs remarks while SFI calls them unscientific and alleges crackdown on protesting students.
A data monitoring committee recommended stopping FLASH2, a randomized double-blind placebo-controlled confirmatory phase 3 ...
This important cross-species study tests whether the corpus callosum contains parallel, segregated pathways for ipsilateral and contralateral visual-field information, rather than mixed inputs from ...
A phase 2 study investigates the combination of cladribine plus low-dose cytarabine and venetoclax alternating with ...
If planets are, as many of your own geophysicists argue, bodies shaped by their own gravity and expressing internal processes ...
Flexible Barrier Films For Electronics Market To Hit US$ 1,104.4 Million By 2033, Growing At A Robust CAGR Of 15.5%. EINPresswire/ -- The global Flexible Barrier Films for Electronics Market is ...
INSTI, Tenofovir-Free Regimen DOR/ISL Gains FDA Approval for HIV This fixed-dose, 2-drug combination is a once-daily, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results